# FDA recall D-1329-2015

> **Mylan Institutional LLC** · Class I · drug recall initiated 2015-04-23.

## Product

Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-0152-01), packaged in 10 x 5 mL Vials per carton (NDC 0069-0152-02), Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY  10017.

## Reason for recall

Presence of Particulate Matter

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1329-2015
- **Recalling firm:** Mylan Institutional LLC
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-04-23
- **Report date:** 2015-08-19
- **Termination date:** 2016-06-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Rockford, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1329-2015

## Citation

> AI Analytics. FDA recall D-1329-2015. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-1329-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*